scholarly journals Synthesis, Antitumor Activity, and Docking Analysis of New Pyrido[3’,2’:4,5]furo(thieno)[3,2-d]pyrimidin-8-amines

Molecules ◽  
2019 ◽  
Vol 24 (21) ◽  
pp. 3952 ◽  
Author(s):  
Sirakanyan ◽  
Spinelli ◽  
Geronikaki ◽  
Hakobyan ◽  
Sahakyan ◽  
...  

Continuing our research in the field of new heterocyclic compounds, herein we report on the synthesis and antitumor activity of new amino derivatives of pyrido[3’,2’:4,5](furo)thieno[3,2-d]pyrimidines as well as of two new heterocyclic systems: furo[2–e]imidazo[1,2-c]pyrimidine and furo[2,3-e]pyrimido[1,2-c]pyrimidine. Thus, by refluxing the 8-chloro derivatives of pyrido[3’,2’:4,5]thieno(furo)[3,2-d]pyrimidines with various amines, the relevant pyrido[3’,2’:4,5]thieno(furo)[3,2-d]pyrimidin-8-amines were obtained. Further, the cyclization of some amines under the action of phosphorus oxychloride led to the formation of new heterorings: imidazo[1,2-c]pyrimidine and pyrimido[1,2-c]pyrimidine. The possible antitumor activity of the newly synthesized compounds was evaluated in vitro. The biological tests evidenced that some of them showed pronounced antitumor activity. A study of the structure–activity relationships revealed that the compound activity depended mostly on the nature of the amine fragments. A docking analysis was also performed for the most active compounds.

2019 ◽  
Vol 16 (6) ◽  
pp. 462-467
Author(s):  
Songtao Li ◽  
Hongling Zhao ◽  
Zhifeng Yin ◽  
Shuhua Deng ◽  
Yang Gao ◽  
...  

A series of new phenanthrene-based tylophorine derivatives (PBTs) were synthesized in good yield and their structures were characterized by 1H-NMR spectroscopy and ESI MS. In vitro antitumor activity of these compounds against five human carcinoma cell lines, including HCT116 (colorectal), BGC-823 (gastric), HepG-2 (hepatic), Hela (cervical) and H460 (lung) cells, was evaluated by MTT assay. Among these PBTs, compound 6b showed the highest antitumor activities against HCT116 and HepG-2 cell lines with IC50 values of 6.1 and 6.4 μM, respectively, which were comparable to that of adriamycin hydrochloride. The structure-activity relationship of these compounds was also discussed based on the results of their antitumor activity.


1985 ◽  
Vol 16 (15) ◽  
Author(s):  
N. I. TRAVEN' ◽  
YU. A. ERSHOVA ◽  
A. S. SOKOLOVA ◽  
V. A. CHERNOV ◽  
T. S. SAFONOVA

2014 ◽  
Vol 74 ◽  
pp. 742-750 ◽  
Author(s):  
Chengyuan Liang ◽  
Juan Xia ◽  
Dong Lei ◽  
Xiang Li ◽  
Qizheng Yao ◽  
...  

1989 ◽  
Vol 42 (11) ◽  
pp. 1673-1683 ◽  
Author(s):  
H. A. KIRST ◽  
K. E. WILLARD ◽  
M. DEBONO ◽  
J. E. TOTH ◽  
B. A. TRUEDELL ◽  
...  

1993 ◽  
Vol 36 (23) ◽  
pp. 3611-3617 ◽  
Author(s):  
Maria Bretner ◽  
Tadeusz Kulikowski ◽  
Jolanta M. Dzik ◽  
Malgorzata Balinska ◽  
Wojciech Rode ◽  
...  

2019 ◽  
Vol 43 (47) ◽  
pp. 18685-18694 ◽  
Author(s):  
Rui-Xue Liu ◽  
Ying-Shu Wu ◽  
Yan-Cheng Liu ◽  
Ru-Yi Luo ◽  
Li-Dong Yang ◽  
...  

Two new cisplatin-like platinum(ii) complexes of new anthrahydrazones showed significant in vitro antitumor efficacies, which were totally different from that of cisplatin.


2002 ◽  
Vol 45 (17) ◽  
pp. 3765-3771 ◽  
Author(s):  
Evelyne Delfourne ◽  
Francis Darro ◽  
Philippe Portefaix ◽  
Chantal Galaup ◽  
Sylvie Bayssade ◽  
...  

1980 ◽  
Vol 35 (11) ◽  
pp. 1470-1475 ◽  
Author(s):  
Bernd Sorg ◽  
Michael Gschwendt ◽  
Heinz Walter Thielmann ◽  
Erich Hecker

Abstract The synthesis of the esters 6d-8d, 9 c and 10 c is described. These compounds are closely structurally related to the irritant and tumorpromoting 12-O-tetradecanoylphorbol-13-acetate (TPA, 2 a) and to phorbol-12,13-didecanoate (PDD, 2 c) except that they possess no cyclopropane ring. Biological tests show that opening or complete removal of the cyclopropane ring leads to nearly total loss of irritant or tumorpromoting (tested in the case of 9 c and 10 c) activity.


1992 ◽  
Vol 35 (20) ◽  
pp. 3672-3677 ◽  
Author(s):  
Mao Chin Liu ◽  
Tai Chun Lin ◽  
Alan C. Sartorelli

Sign in / Sign up

Export Citation Format

Share Document